Litigation for NINTEDANIB ESYLATE
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
US Court Litigation for NINTEDANIB ESYLATE
Patent | Case Name | Docket | Date Filed | Date Terminated | Cause | Court | Jury Demand | Link To Docket |
---|---|---|---|---|---|---|---|---|
10,105,323 | Cipla Ltd. v. Boehringer Ingelheim Pharmaceuticals Inc. | See Plans and Pricing | 2022-03-03 | 2022-07-18 | 35:1 Patent Infringement | District Court, D. Delaware | None | See Plans and Pricing |
10,154,990 | Cipla Ltd. v. Boehringer Ingelheim Pharmaceuticals Inc. | See Plans and Pricing | 2022-03-03 | 2022-07-18 | 35:1 Patent Infringement | District Court, D. Delaware | None | See Plans and Pricing |
7,119,093 | Cipla Ltd. v. Boehringer Ingelheim Pharmaceuticals Inc. | See Plans and Pricing | 2022-03-03 | 2022-07-18 | 35:1 Patent Infringement | District Court, D. Delaware | None | See Plans and Pricing |
9,907,756 | Cipla Ltd. v. Boehringer Ingelheim Pharmaceuticals Inc. | See Plans and Pricing | 2022-03-03 | 2022-07-18 | 35:1 Patent Infringement | District Court, D. Delaware | None | See Plans and Pricing |
>Patent | >Case Name | >Docket | >Date Filed | >Date Terminated | >Cause | >Court | >Jury Demand | >Link To Docket |